Healthcare

This report briefs the Overview of GCC Pharmaceutical Market and the opportunities in the Gulf Cooperation Council (GCC) pharmaceuticals sector. It focuses on opportunities and challenges in the GCC pharmaceuticals sector as well as factors that drive its revenue and earnings. It further highlights the key trends, drivers, and restraints of the GC...

The continuing convergence of healthcare and information communication technologies makes the telehealth industry one of the most confusing yet transformative spaces in the world. Despite many hurdles, telehealth markets continue to be an effective treatment for many shortfalls present in the current healthcare experience, whether it is getting to...

This research service covers the therapeutics for rheumatic diseases market in the United States from 2009 to 2017, with 2011 as the base year. The focus of this research is on biologics and other treatments prescribed as add-on therapies for rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS); background standard ...

The increase in demand for high quality cardiac testing has made diagnostic companies to diversify their products and shift towards genetic biomarkers and advanced point-of-care diagnostics. This research service analyses the cardiac biomarkers diagnostics market in Europe, particularly, for Acute Myocardial Infarction (AMI) and Congestive Heart Fa...

This research service considers products and companies in the obesity surgery devices market in the United States. The market is expected to see many technology advancements in the next decade. Therefore, a thorough understanding of revenue forecasts, unit forecasts, technological advances, and pricing analyses are provided for the markets various...

This deliverable provides insights on the many macro issues facing the life sciences industry which have resulted in consolidation and an increasing number in partnerships. This research service presents merger and acquisition activity by select life sciences participants and business strategies for new drug development, including contract research...

This issue of Vital Signs, released on August 20, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

This issue of Vital Signs, released on August 13, 2012, provides an insight in to the recent advancements in drug delivery. Additionally, a company spotlight is provided for Ratio. Ratio, Inc. is a start-up company focused on the development of a novel hydrogel-powered injectable drug delivery device that is worn like a patch. Reimbursement a...

This study examines the key trends and issues affecting the U.S. hospital health data analytics market, including a review of industry challenges and market drivers and restraints through 2016. It also analyzes the impact of recent legislative mandates on the implementation and usage of information technology, including data analytics, in U.S. hos...